Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 495 | 467 | 753 | 301 | 517 |
| Cost of Goods | 2,038 | 9,082 | 260 | 213 | 147 |
| Gross Profit | -1,543 | -8,615 | 493 | 88 | 370 |
| Operating Expenses | 27,430 | 22,303 | 25,143 | 30,028 | 23,701 |
| Operating Income | -28,935 | -30,836 | -24,390 | -29,727 | -23,184 |
| Interest Expense | 2,271 | 3,093 | 2,612 | 2,545 | 3,000 |
| Other Income | 13,587 | 9,125 | 9,492 | -5,386 | 65,323 |
| Pre-tax Income | -17,619 | -24,804 | -17,510 | -37,658 | 39,139 |
| Net Income Continuous | -17,619 | -24,804 | -17,510 | -37,658 | 39,139 |
| Net Income | $-17,619 | $-24,804 | $-17,510 | $-37,658 | $39,139 |
| EPS Basic Total Ops | -0.09 | -0.19 | -0.11 | -0.24 | 0.28 |
| EPS Basic Continuous Ops | -0.09 | -0.20 | -0.11 | -0.24 | 0.30 |
| EPS Diluted Total Ops | -0.09 | -0.19 | -0.11 | -0.24 | 0.28 |
| EPS Diluted Continuous Ops | -0.09 | -0.20 | -0.11 | -0.24 | 0.30 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.13 | -0.14 | -0.24 | -0.10 |
| EBITDA(a) | $-26,863 | $-29,048 | $-22,525 | $-27,867 | $-21,352 |